Eli Lilly (LLY) Reports Q4: Everything You Need To Know Ahead Of Earnings

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
24/7 Wall St.

Eli Lilly Jumped 6% After Earnings. It’s Up 68% in a Year. Where Does the Target Go Now?

Mounjaro and Zepbound just handed Lilly a blowout quarter, but falling realized drug prices and one-time revenue boosts that ...

Eli Lilly: Softer Growth Ahead (Rating Downgrade)

Eli Lilly stock still looks attractive after strong results, but slowing revenue growth could cap upside. Read the latest analysis on the LLY stock here.

Why You Should Think About Eli Lilly Stock Differently Now

Eli Lilly (LLY) stock is priced at 38.7 times earnings, compared with 21.5 for the S&P 500. Investors evaluating that valuation should weigh what drives it, especially since the company's priorities ...

Should Investors Buy, Sell or Hold Lilly Stock Ahead of Q4 Earnings?

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm Today

Shares of Eli Lilly (LLY) and AbbVie (ABBV) climbed to new record highs on Friday after the pharmaceutical behemoths reported ...
RTTNews

Eli Lilly Declares Q4 2026 Dividend Of $1.73 Per Share

Eli Lilly and Company ( LLY) said its board of directors has declared a fourth-quarter 2026 dividend of $1.73 per share on its outstanding common stock. The dividend is payable on December 10, 2026, ...
Chosunbiz

OliX eases overhang, targets Q4 Korea tech transfer as Lilly tie-up looms

Olix eases overhang, targets Q4 Korea tech transfer on obesity and eye drugs Overhang risk fades as CPS converts, with Q4 tech transfer tests looming for obesity and macular degeneration programs ...